Avadel Pharmaceuticals PLC (AVDL)
17.81
-0.01
(-0.06%)
USD |
NASDAQ |
Apr 26, 16:00
17.83
+0.02
(+0.11%)
After-Hours: 20:00
Avadel Pharmaceuticals Total Liabilities (Quarterly): 76.96M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 76.96M |
| September 30, 2023 | 92.95M |
| June 30, 2023 | 57.78M |
| March 31, 2023 | 178.90M |
| December 31, 2022 | 153.93M |
| September 30, 2022 | 158.20M |
| June 30, 2022 | 161.27M |
| March 31, 2022 | 165.90M |
| December 31, 2021 | 169.02M |
| September 30, 2021 | 165.13M |
| June 30, 2021 | 163.71M |
| March 31, 2021 | 156.44M |
| December 31, 2020 | 149.37M |
| September 30, 2020 | 156.44M |
| June 30, 2020 | 159.28M |
| March 31, 2020 | 175.66M |
| December 31, 2019 | 180.64M |
| September 30, 2019 | 182.85M |
| June 30, 2019 | 183.49M |
| March 31, 2019 | 183.20M |
| December 31, 2018 | 187.52M |
| September 30, 2018 | 203.26M |
| June 30, 2018 | 216.69M |
| March 31, 2018 | 264.81M |
| December 31, 2017 | 167.70M |
| Date | Value |
|---|---|
| September 30, 2017 | 180.96M |
| June 30, 2017 | 182.43M |
| March 31, 2017 | 199.61M |
| December 31, 2016 | 203.41M |
| September 30, 2016 | 211.15M |
| June 30, 2016 | 197.87M |
| March 31, 2016 | 185.31M |
| December 31, 2015 | 145.95M |
| June 30, 2015 | 172.91M |
| March 31, 2015 | 164.16M |
| December 31, 2014 | 149.31M |
| September 30, 2014 | 124.34M |
| June 30, 2014 | 116.77M |
| March 31, 2014 | 103.61M |
| December 31, 2013 | 125.76M |
| September 30, 2013 | 131.92M |
| June 30, 2013 | 128.47M |
| March 31, 2013 | 101.05M |
| December 31, 2012 | 86.81M |
| June 30, 2012 | 108.35M |
| March 31, 2012 | 105.43M |
| December 31, 2011 | 39.61M |
| September 30, 2011 | 40.33M |
| June 30, 2011 | 44.22M |
| March 31, 2011 | 35.96M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
57.78M
Minimum
Jun 2023
183.49M
Maximum
Jun 2019
152.00M
Average
161.27M
Median
Jun 2022
Total Liabilities (Quarterly) Benchmarks
| Trinity Biotech PLC | 81.08M |
| Medtronic PLC | 38.84B |
| Akari Therapeutics PLC | 4.584M |
| Biophytis SA | 17.52M |
| TC BioPharm (Holdings) PLC | 7.957M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 164.70M |
| Shareholders Equity (Quarterly) | 87.74M |
| Current Ratio | 3.641 |
| Net Debt Paydown Yield | 2.15% |